Gastric Adenocarcinoma

Showing NaN - NaN of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Solid Tumors, NSCLC, Melanoma Trial in United States (INBRX-105 - PDL1x41BB antibody, Pembrolizumab)

Recruiting
  • Metastatic Solid Tumors
  • +7 more
  • Scottsdale, Arizona
  • +12 more
Jan 26, 2023

Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal

Recruiting
  • Colorectal Adenocarcinoma
  • +13 more
  • Nanoliposomal Irinotecan
  • Trifluridine and Tipiracil Hydrochloride
  • Atlanta, Georgia
  • +2 more
Jan 6, 2023

Epstein-Barr Virus Positive, Gastric Adenocarcinoma, Mismatch Repair Protein Deficiency Trial in New Brunswick (drug, other,

Recruiting
  • Epstein-Barr Virus Positive
  • +10 more
  • Atlanta, Georgia
  • +2 more
Dec 10, 2022

Gastric Adenocarcinoma, Esophageal Adenocarcinoma, Metastasis Trial in United States (Oxaliplatin, Leucovorin, 5 fluorouracil)

Active, not recruiting
  • Gastric Adenocarcinoma
  • +3 more
  • Duarte, California
  • +6 more
May 10, 2021

Adenocarcinoma of the Gastroesophageal Junction, Gastric Adenocarcinoma, Gastric Cancer Trial in United States (procedure, drug,

Terminated
  • Adenocarcinoma of the Gastroesophageal Junction
  • +2 more
  • FDG-PET
  • +7 more
  • Los Angeles, California
  • +70 more
Sep 10, 2019

NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Birmingham, Alabama
  • +10 more
Jul 17, 2019

Gastric Adenocarcinoma Trial in Atlanta (Gleevec, Taxotere)

Terminated
  • Gastric Adenocarcinoma
  • Gleevec, Taxotere
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
Dec 27, 2007